Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
CureVac

November 2025

CureVac Market Share Analysis for November 2025

CureVac is a global biopharmaceutical company with more than 20 years of experience in developing the mRNA technology for medical purposes.
Year Founded2000
Employees1001 - 5000
Annual Revenue$50M - $75M
curevac.com
CureVac
CureVac (including company regionals)
  • curevac.com
    curevac.com
See more website traffic and engagement information

CureVac Revenue up to November 2025 is 50M - 75M

revenue generated by CureVac top domains

CureVac top domains revenue over 3 years

Revenue for CureVac top domains


Total visits to CureVac's top domains

Understand CureVac market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in CureVac's top domains

Analyze CureVac engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on CureVac's top domains

See how CureVac keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by CureVac

These are the website technologies, by industry, used by CureVac top domains

Widget (5)

Twemoji

Twemoji

Content Management System (4)

WordPress

WordPress

Mobile (4)

Meta Viewport

Meta Viewport

Payment & Currencies (3)

More Technologies

11

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from CureVac

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCureVac AG received financing of $50M on Jul 3rd '24.CureVac will also receive an additional $50m from GSK for monetising part of its royalty stream under an existing licensing agreement.
NewsCureVac AG recognized as 13 Best German Stocks to Invest in Now.CureVac N.V. (NASDAQ:CVAC) is among the 13 Best German Stocks to Invest in Now.
NewsCureVac AG is developing cancer medicines using the same mRNA technology.CureVac is developing cancer medicines using the same mRNA technology that BioNTech uses for its COVID-19 shot.

See all CureVac signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.